tibolone has been researched along with Hyperplasia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cummings, SR; Ettinger, B; Johnson, SR; Kenemans, P; Mol-Arts, M; Seifert, W; Van Os, S; Verweij, PJ | 1 |
Cline, JM | 1 |
Altermatt, HJ; Bersinger, NA; Birkhaeuser, MH; Haenggi, W | 1 |
2 trial(s) available for tibolone and Hyperplasia
Article | Year |
---|---|
Endometrial effects of tibolone in elderly, osteoporotic women.
Topics: Aged; Bone Density Conservation Agents; Carcinoma, Endometrioid; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Female; Humans; Hyperplasia; Metrorrhagia; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal | 2008 |
Placental protein 14 (PP14) does not predict endometrial status under hormone replacement therapy.
Topics: Biopsy; Dydrogesterone; Endometrial Neoplasms; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Hyperplasia; Middle Aged; Norpregnenes; Postmenopause; Pregnancy Proteins | 1997 |
1 other study(ies) available for tibolone and Hyperplasia
Article | Year |
---|---|
Tibolone: example of qualitative and quantitative assessments of the mammary gland.
Topics: Animals; Cell Proliferation; Female; Hormone Replacement Therapy; Hyperplasia; Macaca fascicularis; Mammary Glands, Animal; Norpregnenes; Ovariectomy; Random Allocation | 2007 |